A second autologous hematopoietic cell transplantation is a safe and effective salvage therapy in select relapsed or refractory AL amyloidosis patients

Affiliations

• ¹ Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ² CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• ³ Bone Marrow Transplant Service, Division of Hematology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁴ University of Miami, Miami, FL, USA.
• ⁵ Division of Hematology-Oncology, University of California San Francisco, San Francisco, CA, USA.
• ⁶ McMaster University, Ontario, Canada.
• ⁷ Department of Hematologic Oncology & Blood Disorders Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
• ⁸ King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
• ⁹ University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, USA.
• ¹⁰ Mayo Clinic Rochester, Rochester, MN, USA.
• ¹¹ Vanderbilt University Medical Center, Nashville, TN, USA.
• ¹² University of Alabama at Birmingham, Birmingham, AL, USA.
• ¹³ Division of Hematology, Oncology, and Bone Marrow Transplantation, University of lowa, Iowa City, IA, USA.
• ¹⁴ Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA.
• ¹⁵ Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, PA, USA.
• ¹⁶ Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL, USA.
• ¹⁷ M.D. Anderson Cancer Center, Houston, TX, USA.
• ¹⁸ CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. [email protected].